Moderna COVID-19 Booster & Pneumonia Vaccine

RESEARCH STUDY CURRENTLY ENROLLING
call 757-591-8100

Moderna COVID-19 Booster & Pneumonia Vaccine

50 years of age and older, MALES & FEMALES

This trial examines the combination of a booster dose of the Moderna COVID-19 vaccine (mRNA-1273) combined with one of Merck’s FDA-approved pneumonia vaccines (V110/Pneumovax23 or V114/Vaxneuvance).

EVERYONE WILL BE VACCINATED IN THIS TRIAL! YOU WILL RECEIVE BOTH COVID-19 BOOSTER AND PNEUMONIA VACCINE.

Eligibility
  • Cannot have had any COVID19 Booster
  • Cannot have been diagnosed in the past with COVID19
  • Must have had 2 primary doses of Moderna COVID19 vaccine – 2nd dose being longer than 6 months ago
Trial Duration

3 office visits over approximately 6 months

Compensation

May receive $150 per completed office visit and $25 per completed phone call.

Apply for this Study & take the first step towards better care for yourself today.

  • MM slash DD slash YYYY